Northwestern Mutual Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.14K	Buy	+470	New	+$6.44K	﹤0.01%	3195
2025 Q4	–	Sell	-155	Closed	-$1.55K	–	4018
2025 Q3	$1.55K	Buy	+155	New	+$1.39K	﹤0.01%	3452
2022 Q3	–	Sell	-275	Closed	-$1K	–	3096
2022 Q2	$1K	Buy	+275	New	+$996	﹤0.01%	2989
2021 Q3	–	Sell	-1	Closed	–	–	2995
2021 Q2	$0	Buy	+1	New	+$6	﹤0.01%	2980
2018 Q3	–	Sell	-452	Closed	-$7K	–	2454
2018 Q2	$7K	Buy	+452	New	+$7.93K	﹤0.01%	1917

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's AMRX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 470 shares worth $8.14K. The stake represents ﹤0.01% of the portfolio and ranks #3195 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in AMRX as recently as Q3 2025.

Northwestern Mutual Wealth Management first reported a position in AMRX in Q2 2018 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Northwestern Mutual Wealth Management held 470 shares of Amneal Pharmaceuticals worth $8.14K as of Q2 2026.
Amneal Pharmaceuticals was a new Northwestern Mutual Wealth Management position in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3195 holding.
Northwestern Mutual Wealth Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.